Consumer Genomics Market To Reach $7.20 Billion By 2030

Consumer Genomics Market Growth & Trends

The global consumer genomics market size is expected to reach USD 7.20 billion by 2030, registering a CAGR of 24.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rise in consumer and physician interest in direct-to-consumer (DTC) kits, coupled with a subsequent increase in the sales of DNA test kits, and the growing trend of personalized genomics, are expected to drive market expansion over the forecast period. The most common tests utilize a small number of genetic changes to predict certain health characteristics, reveal common traits, and provide ancestry hints. With the expansion of the variety of health information these tests can uncover, an increasing number of companies are offering genetic testing directly to consumers.

The surge in consumer and physician interest in DTC kits, technological improvements, an increase in consumer genomics applications, supportive governmental policies, and the growing trend of personalized genomics are the primary drivers of market expansion. For instance, according to a ScienceDirect article, direct-to-consumer (DTC) tests became more prevalent in 2022 as they could be purchased without a doctor's prescription.

The COVID-19 pandemichas heightened people's concerns about their health, potentially encouraging them to explore novel and cutting-edge methods like consumer genomics. Therefore, the market is expected to maintain its considerable growth rate over the forecast period due to the increasing efforts in DNA-based research and development, as well as bioinformatics, aimed at creating diagnostic tools and efficient therapies for COVID-19.

 Request a free sample copy or view report summary: Consumer Genomics Market Report

Consumer Genomics Market Report Highlights

• The genetic relatedness segment accounted for the largest revenue share in 2022 due to its involvement in the most common type of paternal testing

• The dissolving microneedle segment is expected to grow at the fastest rate during the forecast period since it requires only one step, and the microneedle does not need to be removed after insertion

• Companies such as FamilyTree DNA; AncestryDNA; 23andMe, Inc.; MyHeritage, and others offer several paternal and maternal tests. These tests provide information about genetic relations and ancestry at an affordable cost

• Asia Pacific is anticipated to experience the fastest CAGR over the forecast period due to the increasing awareness related to DTC genetics and the availability of funding for long-term research initiatives

Consumer Genomics Market Segmentation

Grand View Research has segmented the global consumer genomics market based on application, and region:

Consumer Genomics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Genetic Relatedness

• Ancestry

• Lifestyle, Wellness, & Nutrition

• Diagnostics

• Sports Nutrition & Health

• Reproductive Health

• Personalized Medicine & Pharmacogenetic testing

• Others

Consumer Genomics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Switzerland

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in Consumer Genomics Market

• Ancestry

• Gene By Gene, Ltd. (FamilyTree DNA)

• 23andMe, Inc.

• Color Health, Inc

• Myriad Genetics, Inc

• Mapmygenome

• Positive Biosciences, Ltd

• Futura Genetics

• Helix OpCo LLC

• MyHeritage Ltd.

• Pathway Genomics

• Veritas

• Amgen, Inc.

• Xcode Life

• Diagnomics, Inc.

• Toolbox Genomics

• SomaLogic, Inc.

• inui Health (formerly Scanadu)

• AgeCurve

• QuickCheck Health

• Biomeb

• Metabolomic Discoveries GmbH

• Illumina, Inc.